You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 24, 2025

Details for Patent: 10,792,270


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,792,270
Title:Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease
Abstract: In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dL to about 500 mg/dL, and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.
Inventor(s): Soni; Paresh (Mystic, CT)
Assignee: Amarin Pharmaceuticals Ireland Limited (IE)
Application Number:16/525,388
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a Patent: A Detailed Analysis

When analyzing a patent, such as the United States Patent 10,792,270, it is crucial to delve into its various components, particularly the scope and claims, to comprehend its full implications and protective coverage.

The Anatomy of a Patent

A patent typically consists of four main parts: the front page, drawings, specification, and claims. Each part plays a vital role in defining the invention and the rights afforded to the patent holder[1][4].

Front Page

The front page includes basic information about the patent, such as the patent number, title, inventors, and assignees. It also lists the references cited during the examination process, which are crucial for understanding the prior art and the patent's validity.

Drawings

The drawings provide visual representations of the invention. These are essential for illustrating the various components and how they interact, making it easier to understand the invention described in the specification.

Specification

The specification is the written part of the patent, excluding the front page and drawings. It includes the detailed description and summary of the invention. This section is critical because it provides the context for interpreting the claims. All terminology used in the claims is defined and interpreted consistently with the terminology in the specification[1].

Detailed Description

The detailed description section lays out the enabling disclosure of the invention, describing it in terms that would allow a person with ordinary skill in the field to make or use the invention. It includes the best mode for making and using the invention and often describes different embodiments of the invention[1].

Claims: The Heart of Patent Protection

The claims section is the most critical part of the patent, as it sets the scope of the patent protection. Here’s a detailed look at the types of claims and their significance.

Independent Claims

Independent claims are the broadest claims in the patent and typically start with the word “A” (e.g., “A system …” or “A method …”). These claims do not refer back to another claim and are used to determine if a product or process infringes the patent. If a product infringes even one of the independent claims, it is considered to infringe the patent[1][4].

Dependent Claims

Dependent claims further narrow the scope of an earlier, independent claim. They always explicitly refer to another claim (e.g., “the method of claim 3…”). While dependent claims cannot be used to determine infringement on their own, they are important for interpreting the independent claims and providing a backup position for enforcing the patent. For instance, if an independent claim is found to be invalid, a dependent claim may still be valid[1][4].

Strategic Claim Management

Effective claim management is crucial for maximizing the value of a patent. Here are some key strategies:

Claim Composition

The initial patent application filing fee in the United States covers up to 3 independent claims and a total of 20 claims. However, the quantity of claims does not directly correlate with the patent's strength or value. Instead, the strategic composition and management of these claims are vital. Consolidating concepts into fewer, broader independent claims can facilitate application approval, while adding dependent claims ensures the full quota of claims is utilized[5].

Amending Claims

During the patent prosecution phase, claims are often amended to align with the USPTO requirements for patentability. This process involves consolidating multiple dependent claims into fewer, broader independent claims. Adding a new dependent claim for every claim that is canceled ensures the patent utilizes its full entitlement, enhancing its breadth and flexibility without additional costs[5].

Measuring Patent Scope

The scope of a patent is a critical aspect of its value and effectiveness. Here are some metrics used to measure patent scope:

Independent Claim Length and Count

Research has shown that independent claim length and count can be simple yet effective metrics for measuring patent scope. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Patent Landscape and Trends

Understanding the broader patent landscape is essential for navigating the complexities of patent law.

Prior Art and References Cited

The references cited section lists the prior art considered by the patent office during the examination process. This section is important because it presumes that the patent office correctly evaluated the prior art, making it harder for third parties to challenge the patent's validity using these references[1].

Economic and Statistical Analysis

Datasets like the Patent Claims Research Dataset provided by the USPTO offer detailed information on claims from US patents and applications. These datasets help in analyzing trends in patent scope, claim dependency, and other metrics that are crucial for understanding the patent landscape[2].

Case Study: United States Patent 10,792,270

To illustrate the concepts discussed, let's consider a hypothetical analysis of the United States Patent 10,792,270.

Claims Analysis

  • Independent Claims: Identify the broadest claims that define the scope of the patent protection. These claims will determine whether a product or process infringes the patent.
  • Dependent Claims: Analyze the dependent claims to understand how they narrow down the scope of the independent claims and provide additional protection.

Specification and Drawings

  • Detailed Description: Review the detailed description to understand the invention in terms that would allow a person with ordinary skill in the field to make or use it.
  • Drawings: Examine the drawings to visualize the components and interactions described in the specification.

Strategic Implications

  • Claim Management: Evaluate how the claims were managed during the patent prosecution phase. Check if the full quota of claims was utilized and if the claims were strategically amended to enhance the patent's breadth and flexibility.
  • Patent Scope: Measure the patent scope using metrics like independent claim length and count to understand its potential impact and value.

Key Takeaways

  • Claims are Central: The claims section is the most critical part of a patent, defining the scope of protection.
  • Strategic Claim Management: Effective claim management involves consolidating claims, utilizing the full quota of claims, and strategically amending claims during the prosecution phase.
  • Patent Scope Metrics: Independent claim length and count are useful metrics for measuring patent scope and understanding its implications.
  • Prior Art and References: The references cited section is crucial for understanding the prior art and the patent's validity.
  • Economic Analysis: Datasets and economic research can provide valuable insights into patent trends and the broader patent landscape.

Frequently Asked Questions

What are the main parts of a patent?

The main parts of a patent include the front page, drawings, specification, and claims.

Why are independent claims important?

Independent claims are the broadest claims in the patent and are used to determine if a product or process infringes the patent.

How do dependent claims differ from independent claims?

Dependent claims narrow down the scope of an earlier, independent claim and cannot be used to determine infringement on their own but are important for interpreting independent claims.

What is the significance of the references cited section?

The references cited section lists the prior art considered by the patent office, making it harder for third parties to challenge the patent's validity using these references.

How can patent scope be measured?

Patent scope can be measured using metrics such as independent claim length and count, which have explanatory power for several correlates of patent scope.

Cited Sources

  1. Understanding the Parts of a Patent | Henry Patent Law Firm
  2. Patent Claims Research Dataset - USPTO
  3. Patent Claims and Patent Scope - Search eLibrary :: SSRN
  4. Lesson 3: Parts of a Patent | UW-Madison Libraries
  5. Maximizing Patent Value: A Strategic Approach to Claim Management

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,792,270

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-001 Jul 26, 2012 AB RX Yes Yes ⤷  Try for Free ⤷  Try for Free USE OF VASCEPA AS AN ADJUNCT TO STATIN THERAPY TO REDUCE THE RISK OF CORONARY REVASCULARIZATION IN AN ADULT PATIENT WITH ESTABLISHED CARDIOVASCULAR DISEASE ⤷  Try for Free
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-002 Feb 16, 2017 AB RX Yes No ⤷  Try for Free ⤷  Try for Free USE OF VASCEPA AS AN ADJUNCT TO STATIN THERAPY TO REDUCE THE RISK OF CORONARY REVASCULARIZATION IN AN ADULT PATIENT WITH ESTABLISHED CARDIOVASCULAR DISEASE ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.